FindTrial
Sign In

To study the effect of drug nalbuphine in nerve block in prologing the duration of pain relief

Efficacy of Nalbuphine as an adjuvant to 0.5% Bupivacaine in ultrasound guided Suprazygomatic maxillary nerve block in patients undergoing nasal and maxillofacial surgery - A Randomized clinical comparative study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047436
Enrollment
60
Registered
2022-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: usg guided maxllary nerve block with additive drug: USG guided block with 0.5% bupivacaine 0.1ml/kg with nalbuphine 0.1mg/kg will be given to the group Control Intervention1: USG GUIDED

Sponsors

ESIC medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1-2, AGE BETWEEN 18-60 YRS PATIENTS UNDERGOING ELECTIVE NASAL AND MAXILLOFACIAL SURGERY UNDER GENERAL ANAESTHESIA

Exclusion criteria

Exclusion criteria: ASA GRADE3-4, PATIENT REFFUSAL, KNOWN COAGULATION DISORDERS, KNOWN ALLERGY TO LOCAL ANAESTHETICS, SYSTEMIC DISORDERS, MORBIDLY OBESE PATIETNS.

Design outcomes

Secondary

MeasureTime frame
NUMBER OF RESCUE ANALGESICS USED IN 24 HR POSTOPERATIVE PERIOD INTRA AND POSTOPERATIVE HEMODYNAMIC STABILITYTimepoint: AT 4TH HRLY TILL 24 HRS EVERY 30 MIN DURING INTRAOPERATIVE PERIOD EVERY 2 HRLY POSTOPERATIVE—

Primary

MeasureTime frame
TO COMPARE HE MEAN DURATION OF POSTOPERATIVE ANALGESIA IN BOTH GROUPSTimepoint: TO COMPARE HE MEAN DURATION OF POSTOPERATIVE ANALGESIA IN BOTH GROUPS Every 2hrly post operative rescue analgesia usage—

Countries

India

Contacts

Public ContactDr G B Sumalatha

ESICMedical college

gbsumaravi@gmail.com9538301444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026